Grant opportunity · PAR-25-321
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Who can apply (as listed)
- State governments
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Small businesses
- Independent school districts
- Others (see the opportunity text)
- City or township governments
- Native American tribal governments (federally recognized)
- Public housing authorities / Indian housing authorities
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- Public and state-controlled institutions of higher education
- For-profit organizations (other than small businesses)
- County governments
- Native American tribal organizations (other than federally recognized governments)
- Special district governments
- Private institutions of higher education
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.